Labeled for this condition
Medicines for influenza
5 medicines have an FDA label indicated for influenza; 3 are listed from generic labelers and 0 have a presentation in shortage now (FDA files, October 8, 2026).
Which medicines are labeled for influenza?
Each label names the condition in its indications; the record shows the label's words. A list of labeled medicines is not a treatment plan.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Oseltamivir | Tamiflu | 36 labelers | $0.150 per mL 6 mg/mL suspension | No | No current entry | 3 |
| Amantadine | Gocovri | 34 labelers | $0.143 per capsule 100 mg capsule | No | No current entry | 6 |
| Baloxavir marboxil | Xofluza | none listed | $161.94 per tablet 40 mg tablet | No | No current entry | 0 |
| Zanamivir | Relenza | none listed | n/a | No | No current entry | 0 |
| Rimantadine | none listed | 1 labeler | n/a | No | No current entry | 0 |
Source: FDA drug labels (indications) via openFDA; NDC Directory; CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)
What do pharmacies pay?
Each medicine's most widely listed form, per unit, in the NADAC survey: what pharmacies paid, not what a patient pays; strengths differ, so compare like with like.
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price